McKinsey to pay $78 million in reimbursement for opioids in the U.S. to insurance plans
Consulting firm McKinsey & Co has agreed to pay $78 million to settle claims by US health insurers and benefit plans that it contributed to the opioid addiction epidemic by working for pharmaceutical companies including oxycontin maker Purdue Pharma.
POPULAR POSTS
LIVE STREAM
